Royalty-free license agreement for drug development

Thursday 8 July 2010

The Global Alliance for TB Drug Development has reached an agreement with the Geneva-based Drugs for Neglected Diseases initiative (DNDi) under which it will grant royalty-free rights to DNDi to develop drugs against neglected diseases.

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland